| abstract |
The invention relates to the use of a cyclooxygenase-2 (COX-2) inhibitor for treating psychiatric disorders such as schizophrenia, delusional disorders, affective disorders, autism or tic-related complications, especially chronic schizophrenic psychosis and schizoaffective psychoses, temporary acute psychotic disorders , bouts of depression, bouts of recurrent depression, manic complications and bipolar affective disorders. In addition, the invention relates to the use of a COX-2 inhibitor, in particular celecoxib, in combination with a neuroleptic drug, in particular risperidone, or an antidepressant for the treatment of psychiatric disorders, such as schizophrenia, delusional disorders, affective disorders, autism or complications associated with ticom. Report on the international search was published 2003.05.01. |